You are here

AusPAR: Adalimumab

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

23 September 2020
AusPAR Details
AusPAR
Active Ingredient
Adalimumab
Product Name
Idacio
Sponsor
Fresenius Kabi Australia Pty Ltd
Submission Number
PM-2019-03192-1-1
Submission Type
New biosimilar medicine
Decision
Approved
AusPAR Date
17 September 2020
Publication Date

23 September 2020